Evaluation of the prevalence of digital dermatitis and the effects on performance in beef feedlot cattle under organic trace mineral supplementation.

Bovine digital dermatitis (DD) is a contagious and multifactorial disease that leads to painful, ulcerative lesions of the skin near the heel-horn border of the foot, most commonly in dairy cattle. With regard to beef cattle, the pathogenesis and etiology of DD has not been widely reported or studied over the past several decades. A longitudinal field trial in a commercial feedlot was conducted to compare prevalence and effects of DD in beef steers provided a diet supplemented with a novel formulation of inorganic and organic trace mineral sources (OTM diet) compared to a diet provided with similar levels of trace minerals solely from inorganic sources (CON diet). A secondary objective was to evaluate the prevalence of DD and the potential effects on growth performance and carcass yield and quality. One thousand seventy-seven steers were assigned to 1 of the 2 treatment groups (CON diet or OTM diet) based on location of their home pens which were situated in 1 of 2 barns. All pens in the B barn (group B) were assigned to the OTM diet, and all pens in the A barn (group A) were assigned to the CON diet. The study was conducted in 2 phases: adaptation phase (AP) comprising the initial 60 d of feeding CON and OTM diets and postadaptation phase (PAP) which lasted until cattle were sent to harvest. In the AP, pens in group B had a greater proportion of steers (54.03%) with DD lesions compared to pens in group A (26.72%). During the PAP, the relative risk of observing an increased DD prevalence was significantly ( < 0.05) higher in CON group compared to OTM group. Growth performance, final live weight, and hot carcass weight were negatively impacted when steers were observed to have active DD lesions (M2 lesions) compared to steers with no M2 lesions over the study period. For ADG, a calculated loss per steer of 0.08 kg/d from type I (no M2 lesions) to type II (one M2 lesion; SE = 0.028; = 0.003) and loss of 0.14 kg/d from type I to type III (multiple M2 lesions; SE = 0.038; = 0.0003) were observed. A significant BW loss of approximately 10.06 kg (SE = 4.18; = 0.022) and a mean reduction of 5.5 kg per steer in HCW (SE = 2.74; = 0.043) were also found between type I and type II steers.

The influence of supplemental Zn-amino acid complex and ractopamine hydrochloride feeding duration on growth performance and carcass characteristics of finishing beef cattle.

Previous research indicates that finishing steer ADG and G:F increases linearly with increasing dietary Zn-amino acid complex (ZnAA) supplementation in cattle fed ractopamine hydrochloride (RAC). The objective of this study was to determine the influence of supplemental Zn-amino acid complex on growth performance and carcass characteristics of finishing steers fed RAC for 0, 28, or 42 d prior to harvest. This study was organized as 2 groups (GRP) of steers fed concurrently, for 91 (GRP 1) or 84 d (GRP 2). A total of 324 steers (463 ± 23.4 kg) were fed a corn-based finishing diet supplemented with 60 mg Zn/kg diet DM (as ZnSO). Steers were blocked by weight to pens of 6 steers, and assigned to receive either 0 (CON) or 60 mg supplemental Zn/kg DM from ZnAA ( = 27 pens per treatment). Receiving ZnAA for 49 (GRP 1) or 42 d (GRP 2) prior to start of RAC feeding had no impact on growth of steers ≥ 0.19). Forty-two d prior to harvest, pens were equally assigned within CON or ZnAA treatments to receive RAC at 300 mg∙steer∙d for 0 (NoRAC), 28 (28RAC), or 42 d (42RAC) prior to harvest, creating 6 final treatments ( = 9 pens per treatment). All steers within a GRP were harvested on the same day. Pen was the experimental unit, and the statistical model included the fixed effects of ZnAA, RAC, and block nested within GRP, and the random effect of pen. Ractopamine hydrochloride supplementation increased carcass-adjusted ADG, final BW, HCW, and ribeye area ( ≤ 0.007). There was an effect of ZnAA within 28RAC and 42RAC where carcass-adjusted ADG ( ≤ 0.10), and final BW and HCW ( ≤ 0.05) were greater in ZnAA supplemented vs. CON steers, and 28RAC steers supplemented with ZnAA had improved overall carcass-adjusted G:F relative to CON steers ( = 0.04). However, when steers did not receive RAC there was no effect of ZnAA on final BW, ADG, or HCW ( ≥ 0.78). Additionally, ZnAA supplementation had no effect on the difference in performance between steers supplemented with RAC for 28 vs. 42 d ( 0.21). In conclusion, under the conditions of this study supplemental ZnAA did not prevent the diminished response to RAC as days on RAC increased from 28 to 42. However, there appears to be a synergistic effect of ZnAA on RAC-induced cattle growth, as supplementing 60 mg Zn/kg DM from ZnAA to cattle fed RAC improved overall growth and HCW.

The effects of increasing supplementation of zinc-amino acid complex on growth performance, carcass characteristics, and inflammatory response of beef cattle fed ractopamine hydrochloride.

Forty-two Angus crossbred steers (380 ± 5.3 kg) were enrolled in a finishing study to evaluate the influence of a supplemental Zn amino-acid complex (ZnAA; Availa-Zn) on performance and carcass characteristics of finishing steers in combination with ractopamine hydrochloride (RAC). Steers were stratified by BW into 7 pens of 6 steers each, and individual feed intake was measured. Steers were assigned to 1 of 4 treatments for 86 d (pre-RAC period): a dry-rolled corn-based diet supplemented with 60 mg Zn/kg DM from ZnSO and no supplemental ZnAA (CON; analyzed 88 mg Zn/kg DM; = 6) or CON diet supplemented with 30 (Zn30; = 12), 60 (Zn60; = 12), or 90 (Zn90; = 11) mg Zn/kg DM from ZnAA. Day 86 BW and G:F displayed a quadratic tendency ( = 0.09) with Zn60 steers being greater than the other treatments. Plasma cyclic adenosine monophosphate tended to linearly increase with increasing ZnAA ( = 0.10). On d 88, 6 of 12 steers (one of the 2 pens) receiving supplemental ZnAA was randomly selected to be supplemented with RAC at 300 mg∙steer∙d for the final 28 d of the experiment (RAC period). This created 7 final treatments: CON: no supplemental ZnAA, no RAC ( = 5); Zn30: Zn30, no RAC ( = 5); Zn30R: Zn30 + RAC ( = 6); Zn60: Zn60, no RAC ( = 6); Zn60R: Zn60 + RAC ( = 6); Zn90: Zn90, no RAC ( = 5); and Zn90R: Zn90 + RAC ( = 6). During the RAC period, as supplemental ZnAA increased within RAC-supplemented treatments, there was a linear increase in final BW, ADG, and G:F ( < 0.05). However, there was no effect of supplemental ZnAA on BW, ADG, or G:F during this period in non-RAC fed steers ( ≥ 0.44). Day 111 plasma Cu was increased, plasma Fe decreased, and leukocyte counts and serum interleukin-8 concentrations were greater ( < 0.05) in RAC-fed steers suggesting that RAC may elicit a mild inflammatory response. There was a tendency for increasing Zn supplementation to decrease plasma haptoglobin within RAC-fed steers ( = 0.07), suggesting that Zn may alter the inflammatory response. Overall, Zn60 improved growth performance during the pre-RAC period. Zinc supplemented as ZnAA appears to improve growth in combination with RAC supplementation, suggesting that Zn may enhance or support the biological function of RAC. Additionally, these results indicate that feeding RAC impacts trace mineral status, and potentially causes a non-specific inflammatory response, but further research is required to define this response.

BOARD-INVITED REVIEW: Efficiency of converting digestible energy to metabolizable energy and reevaluation of the California Net Energy System maintenance requirements and equations for predicting dietary net energy values for beef cattle.

For the past several decades, nutrient requirement systems for beef cattle in North America have recommended that dietary ME can be calculated as dietary DE × 0.82, but considerable published data suggest a variable relationship between DE and ME. We reviewed the literature and tabulated the results of 23 respiration calorimetry studies (87 treatment mean data points), in which measurements of fecal, urinary, and gaseous energy were determined with beef cattle (bulls, steers, and heifers) and growing dairy cattle. Mixed-model regression analyses to adjust for the effects of the citation from which the data were obtained suggested a strong linear relationship between ME and DE (Mcal/kg of DM; ME = 0.9611 × DE - 0.2999; = 0.986, root mean square error [RMSE] = 0.048, < 0.001 for intercept, slope ≠ 0). Analysis of residuals from this simple linear regression equation indicated high correlations of residuals with other dietary components, and a slight increase in precision was obtained when dietary CP, ether extract, and starch (% of DM) concentrations were included in a multiple linear regression equation (citation-adjusted = 0.992, RMSE = 0.039). Using the simple linear relationship, we reevaluated the original data used to develop the California Net Energy System (CNES) for beef cattle by recalculating ME intake and heat production and regressing the logarithm of heat production on ME intake (both per BW, kg daily). The resulting intercept and slope of the recalculated data did not differ ( ≥ 0.34) from those reported for the original analyses of the CNES data, suggesting that use of the linear equation for calculating ME concentration was consistent with NEm and NEg values as derived in the CNES. Nonetheless, because the cubic equations recommended by the NRC to calculate dietary NEm and NEg from ME were based on conversion of DE to ME using 0.82, these equations were mathematically recalculated to account for the linear relationship between DE and ME. Overall, our review and analyses suggested that there is a strong linear relationship between DE and ME, which seems to be consistent across a wide range of dietary conditions, cattle types, and levels of intake. Applying this linear relationship to predict ME concentrations agreed with the original CNES calculations for NE requirements, thereby allowing the development of new equations for predicting dietary NEm and NEg values from ME.

Meta-analysis of the effects of laidlomycin propionate, fed alone or in combination with chlortetracycline, compared with monensin sodium, fed alone or in combination with tylosin, on growth performance, health, and carcass outcomes in finishing steers in North America.

The objective of this research was to use data from multiple studies to comprehensively quantify the effects of feeding 1) laidlomycin propionate (LP), alone and/or in combination with chlortetracycline, compared with 2) monensin sodium (MS), alone and/or in combination with tylosin, at commercially approved dosages, on ADG, DMI, feed efficiency (FE), mortality, and carcass characteristics (HCW and liver abscesses). A secondary objective was to explore potential sources of heterogeneity among the comparative effectiveness studies. A systematic review of peer-reviewed literature and industry reports was used to identify studies that included direct comparisons of these treatments in finishing steers in North America. Random-effects meta-analysis models of performance, carcass, and health-related outcomes were fitted with extracted data, consisting of a total of 17 data sets comprising a total of 135 pens and 13,603 steers. Results showed that pens of steers fed LP had increased ADG (live and carcass adjusted), DMI, and HCW compared with those fed monensin ( < 0.05). However, liver abscesses were more common in LP-fed cattle than in MS-fed cattle ( < 0.05), presumably because of differences in the concurrently fed antimicrobials. No significant effects ( > 0.05) were identified for FE or for health-related outcomes (overall and cause-specific mortality). There was a substantial amount of heterogeneity in outcomes among studies, and when pen size and type of production setting were included in mixed-effects meta-regression models, they accounted for only a small proportion of the between-study heterogeneity found in the meta-analysis models. Therefore, caution should be exercised when interpreting summary estimates in the presence of substantial heterogeneity. However, these results provide comprehensive information on the comparative effects of different ionophores across multiple studies and multiple years, states, and production settings. These unique results can enable quantitative and informed decisions by potential end users of these feed additives that are widely used in the U.S. beef industry for reducing the costs of beef production through enhanced cattle performance.

Zinc Methionine Supplementation Impacts Gene and Protein Expression in Calf-Fed Holstein Steers with Minimal Impact on Feedlot Performance.

Providing cattle a more bioavailable zinc (Zn) source prior to administering a beta adrenergic agonist (ßAA) may enhance the metabolic pool of primary nutrients that will influence the magnitude of the ßAA response. Calf-fed Holstein steers were supplemented with a Zn methionine supplement (ZnMet; ZINPRO(®); Zinpro Corporation, Eden Prairie, MN) for 115 ± 5 days prior to harvest along with zilpaterol hydrochloride (ZH; Zilmax(®); Merck Animal Health, Summit, NJ) for the last 20 days with a 3-day withdrawal to evaluate the effects on growth and carcass performance together with gene and protein expression of skeletal muscle, adipose tissue, and fatty acid composition of polar and neutral lipid depots. Steers (n = 1296; initial weight = 468.5 ± 0.5 kg) were sorted by weight, blocked by harvest date, and randomly assigned to pens (n = 12) and treatments: control (90 ppm Zn from ZnSO4) and ZnMet (Control plus 720 mg Zn from ZnMet/hd/d). There were no differences (P > 0.05) in growth performance or carcass characteristics. The ZnMet-fed cattle had reduced (P < 0.05) abundance of myosin heavy chain (MHC)-IIX, ß1-adrenergic receptor (ßAR), peroxisome proliferator-activated receptor gamma, and stearoyl-CoA desaturase mRNA in skeletal muscle tissue. The ZnMet cattle had greater (P < 0.05) abundance of MHC-II protein, increased MHC-IIA and IIX cross-sectional areas (P < 0.05), an increased percentage of MHC-I fibers (P < 0.05), and a decreased percentage of MHC-IIX fibers (P < 0.05). The combination of ZnMet and ZH had positive biological effects on musculoskeletal tissue; however, these molecular effects were not significant enough to impact overall feedlot and carcass performance.

Effects of lasalocid and intermittent feeding of chlortetracycline on the growth of prepubertal dairy heifers.

Forty Holstein heifers entered the 12-wk study at approximately 12 wk of age. At enrollment, heifers were blocked by birth date and assigned to 1 of 4 treatments: (1) carrier (30 g; control); (2) lasalocid + carrier (1 mg/kg of body weight; L); (3) chlortetracycline + carrier (22 mg/kg of body weight; CTC); (4) L + CTC + carrier (CTCL). Heifers on CTC and CTCL were provided treatment Monday through Friday and carrier only on Saturday and Sunday. These heifers were provided their respective treatment during wk 1 to 4, 6, and 10; wk 5, 7 to 9, and 11 to 12 heifers were provided the nonmedicated carrier. Heifers were individually fed a total mixed ration with treatments top-dressed at 1200 h daily. Dry matter intake was monitored for each heifer and feed provided was adjusted according to individual intakes. Skeletal measurements were taken weekly and blood samples were obtained every Monday, Wednesday, and Friday. Blood samples were analyzed for thyroxine concentration via radial immunoassay. Heifers supplemented with L had lower average daily gain , overall body weight gain, and trends for lower daily body length gain and overall girth gain compared with CTC heifers, but similar to control and CTCL heifers. Heifers fed L had lower hip height gain and overall hip height gain compared with CTCL heifers, but similar to control and CTC heifers. Heifers fed L had lower overall withers height gain compared with control heifers, but similar to CTC and CTCL heifers. No treatment effect on thyroxine concentrations was observed. These data indicate that L did not increase growth. Results from this experiment indicate that supplementing heifers with L was not beneficial and no benefits to supplementing heifers with CTC or the combination of CTC and L were evident compared with control heifers. Heifers in this study experienced minimal health problems and were regarded to be under low stress levels. Supplementing CTC and L may be beneficial to growing heifers under conditions where disease exposure and stressors are greater.

Short communication: serum and tissue concentrations of vitamin D metabolites in beef heifers after buccal dosing of 25-hydroxyvitamin D3.

Sixteen crossbred (British x Continental; average un-shrunk body weight = 507.9 kg; SD = 45.6 kg) beef heifers fed a steam-flaked corn-based finishing diet with melengestrol acetate (0.4 mg/heifer daily) included to suppress estrus were used in a completely random design to evaluate the efficacy of buccal administration of 0, 10, 100, or 1000 mg of 25-hydroxyvitamin D3, (25-OH D3). Serum Ca, P, Mg, 25-OH D3, 1,25-dihydroxyvitamin D [1,25-(OH)2 D3], albumin, and protein were measured 24 h before dosing (-24 h), at dosing (0 h), and 6 and 24 h after dosing, after which the cattle were slaughtered at a commercial facility. Samples of kidneys, liver, longissimus lumborum, and triceps brachii were collected and evaluated for concentrations of 1,25-(OH)2 D3. With -24 and 0 h as baseline covariates, a significant time x treatment interaction was observed for serum 25-OH D3 and Ca concentrations, but not for serum 1,25-(OH)2 D3. Supplemental 25-OH D3 doses of 100 and 1000 mg significantly increased serum 25-OH D3 at 24 h after dosing, 1,25-(OH)2 D3 at 6 and 24 h after dosing, and serum Ca at 24 h after dosing. Similarly, buccal dosing of 1000 mg of supplemental 25-OH D3 significantly increased (approximately 2- to 3-fold) concentrations of 1,25-(OH)2 D3 in the kidney, liver, and longissimus lumborum relative to the other 3 treatments but not in triceps brachii. Serum albumin, protein, P, and Mg were not affected by treatment. Based on these results, buccal administration of 100 and 1000 mg 25-OH D3 increased vitamin D3 metabolites in serum and tissues, and it should be an effective method of delivering the vitamin.

Feeding and watering behavior of healthy and morbid steers in a commercial feedlot.

Our objective was to determine whether there were differences in feeding and watering behavior of newly received healthy and morbid feedlot steers. Two separate 32-d feeding trials were conducted in Wellton, Arizona, in July and November 1996. Radio frequency technology was used to record individual animal behaviors from 108 (average weight 139 kg) and 143 (average weight 160 kg) steers in each respective trial. Steers that were subsequently identified as morbid were present at the feed bunk in greater percentages than reported in previous studies. In Trial 1, healthy steers spent more (P < .001) time at the feed bunk and had more (P < .009) feeding bouts than morbid steers. In Trial 2, healthy steers did not spend more time at the feed bunk, but they had more (P < .02) daily feeding bouts than morbid steers. There were no differences in daily time spent at the water trough by healthy or morbid steers in either trial. The greatest proportion of feeding and watering behavior occurred during the daylight hours in response to feed delivery. The pattern of time spent at the feed bunk throughout the 32-d feeding period was similar for healthy and subsequently morbid steers, but healthy steers had more feeding bouts per day.

The logic of job-sharing in the provision and delivery of health care.

By definition the practice of job-sharing starts from the premiss that there is a full-time job to be shared by those who want to balance their work with other commitments. In a public sector institution, such as the National Health Service (NHS), where most employees are female, it seems logical to believe that a job-sharing policy would be able to promote equal opportunities, to increase employee job satisfaction and to reduce labour costs. Hence, this paper attempts to discuss the advantages and disadvantages of having a job-sharing policy, and to analyse the reasons for the limited number of job-sharers in the NHS despite the apparent benefits of job-sharing to both the employees and the employer. This study was carried out in 15 NHS Trusts in northern England and Scotland, by the use of questionnaires and interviews, and found that most NHS managers did not see the practice of job-sharing as a major cost-saving opportunity or as a working pattern that would enhance employee satisfaction and commitment. They saw job-sharing as just a routine equal opportunities request which did not deserve such managerial attention or long-term strategic thinking. It is argued in this paper that job-sharing is a potentially useful option against a background of demographic and other social and economic changes which require the development and use of long-term strategic policies. Therefore it is concluded that, in the NHS, there is a need for a more active and creative approach to job-sharing rather than the reactive and passive approach that has dominated the practice so far.

The logic of job-sharing in the provision and delivery of health care.

By definition the practice of job-sharing starts from the premiss that there is a full-time job to be shared by those who want to balance their work with other commitments. In a public sector institution, such as the National Health Service (NHS), where most employees are female, it seems logical to believe that a job-sharing policy would be able to promote equal opportunities, to increase employee job satisfaction and to reduce labour costs. Hence, this paper attempts to discuss the advantages and disadvantages of having a job-sharing policy, and to analyse the reasons for the limited number of job-sharers in the NHS despite the apparent benefits of job-sharing to both the employees and the employer. This study was carried out in 15 NHS Trusts in northern England and Scotland, by the use of questionnaires and interviews, and found that most NHS managers did not see the practice of job-sharing as a major cost-saving opportunity or as a working pattern that would enhance employee satisfaction and commitment. They saw job-sharing as just a routine equal opportunities request which did not deserve such managerial attention or long-term strategic thinking. It is argued in this paper that job-sharing is a potentially useful option against a background of demographic and other social and economic changes which require the development and use of long-term strategic policies. Therefore, it is concluded that, in the NHS, there is a need for a more active and creative approach to job-sharing, rather than the reactive and passive approach that has dominated the practice so far.

Ardacin for steers grazing endophyte-free fescue pasture: effects on live weight gain, forage intake, nitrogen and fiber digestion, ruminal fluid kinetics, ruminal fermentation, and serum hormones and metabolites.

Growth and digestion studies were conducted to evaluate the use of ardacin as a feedgrade antibiotic for enhancing digestive function and growth in grazing steers. In Exp. 1, 90 yearling steers (average initial BW of 248 kg) used in a randomized complete block design (block = weight group) grazed fescue pasture without supplementation (CON) or with daily supplements (DM basis) of .4% of BW supplemental ground corn (CRN) or .4% of BW supplemental corn supplying 120 mg of ardacin (ARD). In Exp. 2, 12 ruminally and duodenally cannulated steers and three ruminally cannulated steers (Hereford x Angus; average BW of 347 kg) were used to evaluate the effects of the same supplements used in Exp. 1 on ruminal fermentation and digestion. In Exp. 1, ARD-supplemented steers weighed more (P < .01) at the conclusion of the study than CRN steers, which together weighed more (P < .01) than CON steers. Average daily gain was greater (P < .10) in supplemented than in CON steers; ARD steers had greater (P < .01) ADG than CRN steers. In Exp. 2, forage intake and harvesting efficiency did not vary (P > .10) with supplementation or type of supplement, but total intake reflected (P = .03) the addition of corn to the forage diet. Addition of ardacin increased (P = .02) ruminal pH compared with CRN steers. Ardacin decreased ruminal molar proportions of acetate and increased (P = .01) propionate proportions when compared with CRN steers. Total tract N digestibility was affected (P < .10) by supplementation and by addition of ardacin to the diet. Addition of ardacin to the ground corn supplement increased ADG, in part by enhancing acetate:propionate ratios and increasing N digestion.

Effects of dietary virginiamycin on performance and liver abscess incidence in feedlot cattle.

The effects of dietary virginiamycin level on performance and liver abscesses in feedlot cattle were evaluated in seven dose-response studies. Steers and heifers were fed finishing diets ranging in energy content from 1.34 to 1.51 Mcal of NEg/kg of DM. In all studies, virginiamycin added to the diet improved average daily gain and(or) feed conversion, with no substantial effect on dry matter intake. Pooled analyses of four studies providing virginiamycin at 11.0, 19.3, and 27.6 mg/kg of DM in the complete diet indicated that growth and feed conversion were linearly improved (P < .05); feeding 19.3 mg/kg improved these measurements by 3.0 and 3.8%, respectively. Overall incidence (score 0 vs score 1, 2, and 3) and severity (score 0, 1, and 2 vs score 3) of liver abscesses were reduced (P < .01) by feeding virginiamycin at either 19.3 or 27.6 mg/kg. Linear plateau modeling indicated that the effective dose range for virginiamycin in feedlot diets (DM basis) was 19.3 to 27.3 mg/kg for increasing average daily gain, 13.2 to 19.3 mg/kg for improving feed conversion, and 16.5 to 19.3 mg/kg for reducing liver abscess incidence.

Effects of lasalocid and monensin plus tylosin on serum metabolic hormones and clinical chemistry profiles of beef steers fed a 90% concentrate diet.

Fourteen crossbred beef steers (average initial BW 313 +/- 13.1 kg) fed a 90% concentrate diet (as-fed basis) were used to evaluate effects of ionophores on serum metabolic hormones and clinical chemistry profiles. Treatments were no ionophore (C; four steers), lasalocid (L; 33 mg/kg of diet; five steers), and monensin (33 mg/kg of diet) plus tylosin (11 mg/kg of diet; MT; five steers). All steers were adapted to the 90% concentrate diet, after which treatments were applied and blood was sampled via jugular catheters on d 7, 35, 63, 91, and 119 of the trial at 0, 1, 2, 3, 4, 6, 8, and 10 h after feeding. Averaged over sampling days, serum glucose concentrations did not differ (P > .10) among treatments at any sampling time (treatment x sampling time, P < .05). Average across sampling days and times, serum growth hormone, insulin, cholesterol, and triglyceride concentrations did not differ (P > .10) among treatments. No major effects of ionophores were noted for serum enzymes or protein fractions. Averaged over sampling times within day (treatment x day interaction, P < .10), both L and MT increased (P < .05) serum Ca and Na concentrations on d 91 and 119 compared with C. Serum inorganic P was increased (P < .10) for L vs MT and for ionophore treatments compared with C (P < .10) on several occasions (treatment x day x sampling time interaction, P < .05). Results suggest that ionophores do not cause dramatic changes in serum metabolic hormones or clinical chemistry profiles; however, monensin and lasalocid altered serum minerals in beef steers fed a high-concentrate diet.

Effect of rotating monensin plus tylosin and lasalocid on performance, ruminal fermentation, and site and extent of digestion in feedlot cattle.

Two trials were conducted to evaluate the effects of ionophore rotation programs on performance and digestion by feedlot cattle. A 90% concentrate diet was fed with treatments of no ionophore (C), 33 mg lasalocid/kg diet daily (L), 29 mg monensin plus 11 mg tylosin/kg diet daily (MT), and daily (D) and weekly (W) rotation of L and MT. In Trial 1, feedlot performance of 200 crossbred steers (average initial BW 296 kg) was evaluated during a 133-d period. In Trial 2, four crossbred steers (average initial BW 376 kg) fitted with ruminal, duodenal and ileal cannulas were used in a 4 x 4 Latin square design to evaluate treatment effects (excluding W) on ruminal fermentation and site and extent of digestion. In Trial 1, daily rotation of L and MT improved (P less than .10) feed:gain ratio compared with other treatment groups, but daily feed intake did not differ (P greater than .10) among treatments. Daily gain was greater (P less than .10) for steers fed D than for those fed C or MT, but not different from that of steers fed L or W. Carcass measurements did not differ (P greater than .10) among treatments. In Trial 2, ruminal molar proportions of butyrate and valerate were decreased (P less than .07) by MT and D compared with C and L. Proportions of other VFA, ammonia concentrations and ruminal pH did not differ among treatments. Ionophore treatments did not affect site or extent of digestion of OM, starch or N; no differences among treatments were observed for efficiency of microbial protein synthesis. Although daily rotation of L and MT improved performance of growing-finishing feedlot steers, this improvement was not attributable to alterations in ruminal fermentation, or in site or extent of nutrient digestion.

Influence of grain and monensin supplementation on ruminal fermentation, intake, digesta kinetics and incidence and severity of frothy bloat in steers grazing winter wheat pastures.

Three 10-d collection periods (April 4 to 14, early April, EApr; April 23 to May 3, late April, LApr; May 10 to 20, 1984, mid-May, MMay) were conducted to evaluate effects of no supplement (C), .5 kg-head-1.d-1 (as-fed basis) supplemental grain (steam-flaked milo, G) or G plus 170 mg monensin.head-1.d-1 (M) on forage intake and digestion by 12 ruminally cannulated beef steers (four/treatment; avg initially BW = 393 kg) grazing irrigated winter wheat pasture. Ruminal pH was greater (P less than .01) for M than for C or G during EApr but was not altered by treatments in LApr or MMay. Compared with C, ruminal NH3 was decreased (P less than .10) by G and M (5 h after supplementation) in EApr, decreased (P less than .05) by G (2h) and increased (P less than .05) by M (8 h) in LApr and decreased (P less than .10) by G (-1h) in MMay. Treatments had little influence on total VFA concentrations or on molar proportions of acetate and propionate. Butyrate molar proportion was decreased (P less than .10) by M during EApr and LApr, but not during MMay. Monensin increased (P less than .05) fluid passage rate compared with C and G in EApr but not in other periods, Particulate passage measurements did not differ (P greater than .10) among treatments within periods. Forage DM intake was not influenced (P greater than .10) by supplementation during any period. Extent of in situ forage DM disappearance was greater (P less than .10) for M than for C or G during EApr (12 and 30 h of incubation) but was not different (P greater than .10) in LApr or MMay. Incidence of frothy bloat was decreased (P less than .05) by M during EApr; this reduction may have been related to effects of M on ruminal pH, forage digestion and fluid passage.